4-methyl-1,5,6,7-tetrahydro-2H-cyclopenta[d]pyrimidin-2-one, 95.0%, 250mg

1-Methyl-4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]piperazine, 95.0%, 5g

5-Dimethylamino-2-(2-pyridylazo)phenol [for Determination of Zinc in Serum]>98.0%(HPLC)100mg

3-(Difluoromethoxy)cinnamic acid, 5g

Cyazofamid>97.0%(HPLC)(N)1g

6-Methoxychroman-4-amine hydrochloride, 95.0%, 250mg

4-Chloro-6-iodo-1H-indazole, 95.0%, 250mg

Pyrrolidine, 2-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]diphenylmethyl]-, (2R)-, 98%, 10g

Flat flange reaction vial DURAN®, DN 100, 500 ml, 138 mm, 106 mm, Height, 120 mm, 1 Piece

4'',5''-Bis(4'-carboxy[1,1'-biphenyl]-4-yl)[1,1':4',1'':2'',1''':4''',1''''-quinquephenyl]-4,4''''-dicarboxylic acid, 98%, 1g

Ethyl N-[(2-Boc-amino)ethyl]glycinatehydrochloride, 97.0%, 5g

4-Chloro-2-methanesulfonyl-6-methoxy-pyrimidine, 97.0%, 250mg

(2S,4S)-4-Fluoropyrrolidine-2-carboxylic acid, 95.0%, 250mg